¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Beta adrenergic blocking agents"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
Beta-Adrenergic Blocking Agents
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
adrenergic blocking agent
¾Æµå·¹³¯¸°Â÷´ÜÁ¦
beta-adrenergic receptor kinase
º£Å¸¾Æµå·¹³¯¸°¼ö¿ëüÀλêÈÈ¿¼Ò
autonomic blocking agent
ÀÚÀ²½Å°æÂ÷´ÜÁ¦
adrenergic
1. ¾Æµå·¹³¯¸°- 2. ¾Æµå·¹³¯¸°¼º¾à
adrenergic antagonist
¾Æµå·¹³¯¸°´ëÇ×Á¦, ¾Æµå·¹³¯¸°±æÇ×Á¦
adrenergic blocker
¾Æµå·¹³¯¸°Â÷´ÜÁ¦
adrenergic drug
¾Æµå·¹³¯¸°ÀÛ¿ë¾à
adrenergic fiber
¾Æµå·¹³¯¸°¼¶À¯
adrenergic receptor
¾Æµå·¹³¯¸°¼ö¿ëü
blocking agent
Â÷´ÜÁ¦
blocking antibody
Â÷´ÜÇ×ü
blocking of thought
»ç°íµÎÀý
cholinergic blocking agent
Äݸ°Â÷´ÜÁ¦
ganglionic blocking agent
½Å°æÀýÂ÷´ÜÁ¦
minimal blocking concentration
ÃÖ¼ÒÂ÷´Ü³óµµ
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
7
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
blocking agent
Â÷´ÜÁ¦
blocking antibody
Â÷´ÜÇ×ü
blocking of thought
»ç°íµÎÀý
beta-carotene
º£Å¸Ä«·Îƾ
beta cell
º£Å¸¼¼Æ÷
beta hemolysis
º£Å¸¿ëÇ÷
beta ray
º£Å¸¼±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
beta-adrenergic receptor kinase
º£Å¸¾Æµå·¹³¯¸°¼º¼ö¿ëüÀλêÈÈ¿¼Ò
adrenergic blocking agent
¾Æµå·¹³¯¸°Â÷´ÜÁ¦
adrenergic
¾Æµå·¹³¯¸°¼º¾à, ¾Æµå·¹³¯¸°-
adrenergic blocker
¾Æµå·¹³¯¸°Â÷´ÜÁ¦
adrenergic drug
¾Æµå·¹³¯¸°ÀÛ¿ë¾à
adrenergic fiber
¾Æµå·¹³¯¸°¼¶À¯
adrenergic receptor
¾Æµå·¹³¯¸°¼ö¿ëü
adrenergic antagonist
¾Æµå·¹³¯¸°´ëÇ×Á¦
beta cell
º£Å¸¼¼Æ÷
beta counting
º£Å¸°è¼ö
beta emitter
º£Å¸¹æÃâ±â
beta error
Á¦ÀÌÁ¾¿À·ù
beta hemolysis
º£Å¸¿ëÇ÷, ¿ÏÀü¿ëÇ÷
beta particle
º£Å¸ÀÔÀÚ
beta ray
º£Å¸¼±
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
H2 recepor blocking agents, for ulcers
H2¼ö¿ëüÂ÷´ÜÁ¦(â¥é»ô÷ó´Ó¨ð¥)
Chemosensitizing agents
ÈÇÐÀû °¨°¢Á¦
health care agents
°Ç°°ü¸®¿ä¿ø(ÊÙËíËô), °Ç°°ü¸®±â±¸.
immunosuppressive agents
¸é¿ª¾ïÁ¦ÀÎÀÚ(¡åäð¤ì×í)
11-beta-hydroxylase
11-º£Å¸-¼ö»êÈÈ¿¼Ò, 11-º£Å¸-È÷µå·Ï½Ç¶óÁ¦
3-beta-hydroxysteroid dehydrogenase
3-º£Å¸-È÷µå·Ï½Ã½ºÅ×·ÎÀ̵å Å»¼ö¼ÒÈ¿¼Ò
O-Nitrophenyl-beta-galactoside => ONPG
O-´ÏÆ®·ÎÆä´Ò-º£Å¸-°¥¶ôÅä½Ãµå
acetyl-beta-methylcholine
¾Æ¼¼Æ¿-º£Å¸-¸ÞÆ¿Äݸ°
alpha/beta (¥á/¥â) ratio
¥á/¥â ºñ
gamma-delta-beta thalassemia
°¨¸¶-µ¨Å¸-º£Å¸- ÁöÁßÇØ¼ººóÇ÷
hypoglycemia, beta cell tumor
ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
Ganglionic blocking drugs
½Å°æÀýÂ÷´Ü¾àÁ¦(ãêÌèï½ó´Ó¨å·ð¥)
adrenergic stimulating drug
¾Æµå·¹³¯¸°ÈïºÐ¾à, ¾Æµå·¹³¯¸°ÀÚ±ØÁ¦.
adrenergic tone
¾Æµå·¹³¯¸°¼º ±äÀåµµ
adrenergic transmission
¾Æµå·¹³¯¸°¼ºÀü´Þ
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
beta-ARK : beta-adrenergic receptor kinase
º£Å¸-¾Æµå·¹³¯¸°(¼º)¼ö¿ëü ÀλêÈÈ¿¼Ò.
adrenergic blocking agent
¾Æµå·¹³¯¸°Â÷´ÜÁ¦.
adrenergic blocking agent
¾Æµå·¹³¯¸°¼º Â÷´ÜÁ¦
adrenergic blocking agent
¾Æµå·¹³¯¸°(¼º) ºÀ¼â<Â÷´Ü>¾à.
beta adrenergic receptor
º£Å¸¾Æµå·¹³¯¸°¼º ¼ö¿ëü(¼ö¿ë±â, °¨¼öü)
beta-adrenergic antagonist
º£Å¸ ¾Æµå·¹³¯¸°¼º ÀúÇØÁ¦
beta-adrenergic receptor
º£Å¸ ¾Æµå·¹³¯¸°¼º ¼ö¿ëü
biologic agents
»ý¹°ÇÐÀûÁ¦Á¦
eaton agents
ÀÌÆ° º´¿øÃ¼
health care agents
°Ç°°ü¸®¿ä¿ø(ÊÙËíËô), °Ç°°ü¸®±â±¸.
immunosuppressive agents
¸é¿ª¾ïÁ¦ÀÎÀÚ(¡åäð¤ì×í)
law for control of poisonous and powerful agents
µ¶±Ø¹°Ãëü¹ý(ËÄË»ËŅ̬̃ ËÑ).
oral hypoglycemic agents
°æ±¸´ç´¢º´¾àÁ¦(ÌèÏ¢ÓØèñÜ»å·ð¥).
oral hypoglycemic agents
°æ±¸´ç´¢º´¾àÁ¦(ÌèÏ¢ÓØèñÜ»å·ð¥).
proteolytic agents
´Ü¹éºÐÇØÁ¦(¡ÝÂú°ð¥).
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½